CVS Health Corp (CVS)

CVS (NYSE:Health Services) EQUITY
$92.73
pos +0.00
+0.00%
Today's Range: 0.00 - 0.00 | CVS Avg Daily Volume: 5,191,000
Last Update: 07/27/16 - 4:01 PM EDT
Volume: 0
YTD Performance: -5.16%
Open: $0.00
Previous Close: $92.73
52 Week Range: $81.37 - $113.65
Oustanding Shares: 1,074,022,092
Market Cap: 100,796,973,334
6-Month Chart
TheStreet Ratings Grade for CVS
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 14 14 14 15
Moderate Buy 2 2 3 3
Hold 4 4 3 2
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.50 1.50 1.42 1.33
Latest Dividend: 0.42
Latest Dividend Yield: 1.81%
Dividend Ex-Date: 07/19/16
Price Earnings Ratio: 20.45
Price Earnings Comparisons:
CVS Sector Avg. S&P 500
20.45 20.30 12.90
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-9.71% -15.52% 49.66%
GROWTH 12 Mo 3 Yr CAGR
Revenue 10.00 0.20 0.07
Net Income 12.80 0.30 0.10
EPS 16.90 0.50 0.15
Earnings for CVS:
EBITDA 11.55B
Revenue 153.29B
Average Earnings Estimates
Qtr (06/16) Qtr (09/16) FY (12/16) FY (12/17)
Average Estimate $1.30 $1.55 $5.82 $6.57
Number of Analysts 23 22 24 24
High Estimate $1.32 $1.65 $5.90 $6.80
Low Estimate $1.29 $1.46 $5.74 $6.42
Prior Year $1.22 $1.28 $5.16 $5.82
Growth Rate (Year over Year) 6.81% 20.74% 12.82% 12.85%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
Oil stocks surge ahead of Brexit vote and Walmart strikes a deal with China.  
Bearish
Jun 20, 2016 | 7:17 AM EDT
CVS was downgraded to Equal-weight, Morgan Stanley said. $104 price target. Company is facing increased competition in the PBM market.&...
A close below $90 will likely precipitate further declines.
The company's integrated package of health products and services will continue to drive its growth.
Update
Jun 08, 2016 | 6:59 AM EDT
Goldman Sachs Global Healthcare Conference (Day 2 of 3) - 06/07/16 - 06/09/16 CA
In addition to revenue growth, the stock has shown strong growth in return on equity.
In addition to revenue growth, the stock has shown strong growth in return on equity.
Over the past 12 months, shares have made no upside progress.
Predicting the unpredictable has never proven to be a long-term investment strategy.
Even if its first quarter hits the mark, it may be difficult for TGT stock to shake the sector's woes.

Columnist Conversations

Interface (TILE) posted 32-cents in its Q2 period versus a 28-cent consensus estimate.  Revenues also ...
Markets in rally mode as Fed once again decides to leave rates unchanged in 9-1 vote.   Some big moves...
UPS will be reporting its 2nd quarter results before Friday's opening bell.  The stock has been fading si...
The FOMC essentially recycled the past couple of of policy statements at the conclusion of its two-day meeting...

REAL MONEY'S BEST IDEAS

News Breaks

Powered by

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.